Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval
World’s first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India,
Read More